Royal Bank of Canada’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-16
Closed -$1K 7304
2024
Q2
$1K Buy
16
+15
+1,500% +$786 ﹤0.01% 6882
2024
Q1
$0 Sell
1
-11
-92% -$557 ﹤0.01% 7467
2023
Q4
$1K Sell
12
-36
-75% -$1.64K ﹤0.01% 6967
2023
Q3
$2K Sell
48
-1,040
-96% -$60.9K ﹤0.01% 6810
2023
Q2
$79K Buy
1,088
+1,040
+2,167% +$84.6K ﹤0.01% 5509
2023
Q1
$4K Sell
48
-870
-95% -$70.1K ﹤0.01% 6633
2022
Q4
$89K Buy
918
+870
+1,813% +$94K ﹤0.01% 5539
2022
Q3
$5K Sell
48
-2
-4% -$233 ﹤0.01% 6743
2022
Q2
$6K Hold
50
﹤0.01% 6590
2022
Q1
$4K Hold
50
﹤0.01% 7331
2021
Q4
$4K Buy
+50
New +$3.11K ﹤0.01% 7283
2020
Q4
Sell
-13
Closed 7238
2020
Q3
$0 Sell
13
-70
-84% -$1.68K ﹤0.01% 6862
2020
Q2
$1K Buy
83
+20
+32% +$331 ﹤0.01% 6470
2020
Q1
$1K Buy
63
+22
+54% +$411 ﹤0.01% 6476
2019
Q4
$0 Hold
41
﹤0.01% 7055
2019
Q3
$0 Buy
41
+21
+105% +$417 ﹤0.01% 7019
2019
Q2
$0 Hold
20
﹤0.01% 7109
2019
Q1
$1K Hold
20
﹤0.01% 6677
2018
Q4
$1K Hold
20
﹤0.01% 6600
2018
Q3
$1K Hold
20
﹤0.01% 6616
2018
Q2
$1K Sell
20
-2
-9% -$66 ﹤0.01% 6377
2018
Q1
$1K Hold
22
﹤0.01% 6219
2017
Q4
$0 Hold
22
﹤0.01% 6806
2017
Q3
$0 Buy
22
+2
+10% +$43 ﹤0.01% 6918
2017
Q2
$0 Hold
20
﹤0.01% 6715
2017
Q1
$0 Buy
+20
New +$406 ﹤0.01% 6784
2014
Q2
Hold
0
6089
2014
Q1
Hold
0
6094

Other funds holding PRPH

Royal Bank of Canada's PRPH Position: Q3 2024 in Review

Royal Bank of Canada sold out of ProPhase Labs (PRPH) in Q3 2024, closing a stake of 16 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in PRPH in Q1 2017 and held it in 26 quarters. The position peaked at $89K in Q4 2022. 27 funds tracked by Wall St. Rank hold PRPH as of Q3 2024.

  • Royal Bank of Canada reported no remaining ProPhase Labs position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 16 ProPhase Labs shares in Q3 2024, an estimated $1K.
  • Royal Bank of Canada first reported a position in ProPhase Labs in Q1 2017 and held it in 26 quarters.
  • Royal Bank of Canada's ProPhase Labs position peaked at $89K in Q4 2022.
  • 27 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.